These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 32908630)

  • 1. Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside.
    Bladowski M; Gawrys J; Gajecki D; Szahidewicz-Krupska E; Sawicz-Bladowska A; Doroszko A
    Oxid Med Cell Longev; 2020; 2020():2979260. PubMed ID: 32908630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
    de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the Plasma and Platelet Nitric Oxide Biotransformation Metabolites during Ischemic Stroke-A Dynamic Human LC/MS Metabolomic Study.
    Bladowski M; Szahidewicz-Krupska E; Wiśniewski J; Fortuna P; Chojdak-Łukasiewicz J; Budrewicz S; Fleszar M; Doroszko A
    Antioxidants (Basel); 2022 May; 11(5):. PubMed ID: 35624819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential eNOS-signalling by platelet subpopulations regulates adhesion and aggregation.
    Radziwon-Balicka A; Lesyk G; Back V; Fong T; Loredo-Calderon EL; Dong B; El-Sikhry H; El-Sherbeni AA; El-Kadi A; Ogg S; Siraki A; Seubert JM; Santos-Martinez MJ; Radomski MW; Velazquez-Martinez CA; Winship IR; Jurasz P
    Cardiovasc Res; 2017 Dec; 113(14):1719-1731. PubMed ID: 29016749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide released from activated platelets inhibits platelet recruitment.
    Freedman JE; Loscalzo J; Barnard MR; Alpert C; Keaney JF; Michelson AD
    J Clin Invest; 1997 Jul; 100(2):350-6. PubMed ID: 9218511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review and discussion of platelet nitric oxide and nitric oxide synthase: do blood platelets produce nitric oxide from L-arginine or nitrite?
    Gambaryan S; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1779-93. PubMed ID: 25929585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy.
    Ognibene DT; Moss MB; Matsuura C; Brunini TM; de Moura RS; Mendes-Ribeiro AC; Resende AC
    Hypertens Res; 2010 Sep; 33(9):899-904. PubMed ID: 20555333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of non-surgical periodontal treatment on the L-arginine-nitric oxide pathway and oxidative status in platelets.
    Siqueira MA; Fischer RG; Pereira NR; Martins MA; Moss MB; Mendes-Ribeiro AC; Figueredo CM; Brunini TM
    Exp Biol Med (Maywood); 2013 Jun; 238(6):713-22. PubMed ID: 23918883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds.
    Kumar A; Sushama A; Manral S; Sinha R; Joshi R; Singh U; Rohil V; Prasad AK; Parmar VS; Raj HG
    Nitric Oxide; 2012 Jan; 26(1):9-19. PubMed ID: 22100620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene.
    Freedman JE; Sauter R; Battinelli EM; Ault K; Knowles C; Huang PL; Loscalzo J
    Circ Res; 1999 Jun; 84(12):1416-21. PubMed ID: 10381894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of nitric oxide synthase activity in human platelets by nitroglycerin and authentic nitric oxide.
    Chen LY; Mehta JL
    J Investig Med; 1997 Feb; 45(2):69-74. PubMed ID: 9084577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective nitric oxide-cyclic guanosine monophosphate signaling in patients with bipolar disorder: a potential role for platelet dysfunction.
    Fontoura PC; Pinto VL; Matsuura C; Resende Ade C; de Bem GF; Ferraz MR; Cheniaux E; Brunini TM; Mendes-Ribeiro AC
    Psychosom Med; 2012 Oct; 74(8):873-7. PubMed ID: 23023680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein VI mediates platelet nitric oxide synthesis in response to collagen.
    Riba R; Sharifi M; Farndale RW; Naseem KM
    Thromb Haemost; 2005 Aug; 94(2):395-403. PubMed ID: 16113831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation in arterial hypertension: is there a nitric oxide-urea connection?
    Moss MB; Siqueira MA; Mann GE; Brunini TM; Mendes-Ribeiro AC
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):167-72. PubMed ID: 19566824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets.
    Fleming I; Schulz C; Fichtlscherer B; Kemp BE; Fisslthaler B; Busse R
    Thromb Haemost; 2003 Nov; 90(5):863-71. PubMed ID: 14597982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders.
    Gawrys J; Gajecki D; Szahidewicz-Krupska E; Doroszko A
    Oxid Med Cell Longev; 2020; 2020():1015908. PubMed ID: 32215167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nutritional status on the L-arginine-nitric oxide pathway in platelets from hemodialysis patients.
    da Silva CD; Brunini TM; Reis PF; Moss MB; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
    Kidney Int; 2005 Nov; 68(5):2173-9. PubMed ID: 16221216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.
    Pluta RM
    Neurol Res; 2006 Oct; 28(7):730-7. PubMed ID: 17164036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
    Toutouzas K; Riga M; Stefanadi E; Stefanadis C
    Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.